Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent PRANA Biotechnology Research

DURHAM, N.C., March 24, 2011 (GLOBE NEWSWIRE) -- Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp. (OTCBB:CURX) (Frankfurt:8CX), commented today on recent research results reported by Prana Biotechnology.